About OptiMedica
OptiMedica is a company based in Santa Clara (United States) founded in 2004 was acquired by Abbott in July 2013. OptiMedica has raised $95.04 million across 4 funding rounds from investors including Abbott, Kleiner Perkins and BlackRock. OptiMedica offers products and services including Cataract Surgery IOL, Phacoemulsification System, Laser Cataract Surgery System, and ACUVUE Contact Lenses. OptiMedica operates in a competitive market with competitors including LensAR, LensX Lasers, IanTech, Lumedica and Lightmed, among others.
- Headquarter Santa Clara, United States
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Johnson & Johnson Vision Care, Inc.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of OptiMedica
OptiMedica offers a comprehensive portfolio of products and services, including Cataract Surgery IOL, Phacoemulsification System, Laser Cataract Surgery System, and ACUVUE Contact Lenses.
Implants for cataract removal and vision improvement.
Device for efficient cataract extraction during surgery.
Laser system to enhance precision in cataract procedures.
Lenses for daily wear and myopia management support.
Funding Insights of OptiMedica
OptiMedica has successfully raised a total of $95.04M across 4 strategic funding rounds. The most recent funding activity was a Series E round of $35 million completed in November 2012. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
Investors in OptiMedica
OptiMedica has secured backing from 6 investors, including venture fund and institutional investors. Prominent investors backing the company include Abbott, Kleiner Perkins and BlackRock.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Early stage venture capital firm investing in the US
|
Locked | Locked | Locked | |
|
Mid-stage venture capital investments and support for tech entrepreneurs.
|
Locked | Locked | Locked | |
|
Government-backed investments are directed toward healthcare, fintech, and various sectors.
|
Locked | Locked | Locked |
Investor details for OptiMedica
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by OptiMedica
Investment portfolio details for OptiMedica
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - OptiMedica
Detailed financials for OptiMedica
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Optimedica Comparisons
Peer comparison for OptiMedica
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of OptiMedica
OptiMedica operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as LensAR, LensX Lasers, IanTech, Lumedica and Lightmed, among others.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| Locked | Locked | Locked |
Laser and 3D imaging technology for cataract surgery is developed.
|
|
| Locked | Locked | Locked |
Surgical lasers for cataract repair are developed and supplied.
|
|
| Locked | Locked | Locked |
Interventional devices for cataract removal procedures are developed by IanTech.
|
|
| Locked | Locked | Locked |
Lumedica is focused on developing affordable optical imaging devices.
|
|
| Locked | Locked | Locked |
LIGHTMED manufactures and sells medical lasers for eye, dental, and dermatology applications.
|
Detailed competitors of OptiMedica
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Optimedica
Complete news archive for OptiMedica
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about OptiMedica
OptiMedica was founded in 2004 and raised its 1st funding round 2 years after it was founded.
OptiMedica is headquartered in Santa Clara, United States. It is registered at Santa Clara, California, United States.
OptiMedica is a funded company, having raised a total of $95.04M across 4 funding rounds to date.
Developer of medical devices to treat ocular diseases. The company develops Catalys Precision Laser System is a cataract surgery system based on high-precision ablation using femtosecond laser technology. Also, it develops the PASCAL Method of retinal photocoagulation.
OptiMedica's top competitors include LensAR, LensX Lasers and Lumedica.
OptiMedica offers Cataract Surgery IOL, Phacoemulsification System, Laser Cataract Surgery System, and ACUVUE Contact Lenses.
OptiMedica has 6 investors. Key investors include Abbott, Kleiner Perkins, BlackRock, Alloy Ventures, and DAG Ventures.